Format

Send to

Choose Destination
Hum Vaccin. 2011 May;7(5):585-9. Epub 2011 May 1.

Considerations on the clinical application of the human papillomavirus vaccine in Spain.

Author information

1
Coordinator of the Spanish HPV Vaccine Group, Palma de Mallorca, Spain.

Abstract

The circumstances that in the opinion of the authors influence the lower than expected uptake of the vaccine against human papillomavirus in Spain are analyzed. Among others, aspects related to doubts about efficacy and safety, the attitude of the Spanish health authorities or the role of media and the antivaccine groups, as well as the vaccination "culture" of the gynecologist, are discussed. The authors conclude that only with the coordinated effort of all involved bodies in the vaccination process (health authorities, scientific societies, social agents, media...) wide coverage of HPV vaccine will be achieved.

PMID:
21552002
[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center